Correction: Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer

Huihong Jiang; Erjiang Tang; Dan Xu; Ying Chen; Yong Zhang; Min Tang; Yihua Xiao; Zhiyong Zhang; Xiaxing Deng; Huaguang Li; Moubin Lin

doi:10.18632/oncotarget.26274

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer

PDF | How to cite

Oncotarget. 2018; 9:35373-35373. https://doi.org/10.18632/oncotarget.26274

Metrics: PDF 1238 views | ?

Huihong Jiang^1,*, Erjiang Tang^2,*, Dan Xu², Ying Chen², Yong Zhang³, Min Tang³, Yihua Xiao³, Zhiyong Zhang⁴, Xiaxing Deng¹, Huaguang Li² and Moubin Lin^2,3

¹ Department of General Surgery, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
² Center for Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai, China
³ Department of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai, Chinaa
⁴ Department of General Surgery, Zhuji People’s Hospital of Zhejiang Province, Zhejiang, China
^* These authors have contributed equally to this work

Published: October 19, 2018

This article has been corrected: The correct Grant support information is given below:

GRANT SUPPORT

This work was supported by grants from the National Natural Science Foundation of China (grant no. 81272480) and the Natural Science Foundation of Shanghai (grant no. 15411969900, no. ZK2015A32, and no. 201540132). This work was also supported by the grant from Shanghai Municipal Commission of Health and Family Planning (201540132).

Original article: Oncotarget. 2017; 8:29857-29864. DOI: https://doi.org/10.18632/oncotarget.16167.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26274

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer